section_path: Economy/Science and technology
section_name: Science and technology
paragraph_text: Science and technology
  
  Argentines have received three Nobel Prizes in the Sciences. Bernardo Houssay, the first Latin American recipient, discovered the role of pituitary hormones in regulating glucose in animals, and shared the Nobel Prize in Physiology or Medicine in 1947. Luis Leloir discovered how organisms store energy converting glucose into glycogen and the compounds which are fundamental in metabolizing carbohydrates, receiving the Nobel Prize in Chemistry in 1970. César Milstein did extensive research in antibodies, sharing the Nobel Prize in Physiology or Medicine in 1984. Argentine research has led to treatments for heart diseases and several forms of cancer. Domingo Liotta designed and developed the first artificial heart that was successfully implanted in a human being in 1969. René Favaloro developed the techniques and performed the world's first coronary bypass surgery.
  
  Argentina's nuclear programme has been highly successful. In 1957 Argentina was the first country in Latin America to design and build a research reactor with homegrown technology, the RA-1 Enrico Fermi. This reliance on the development of its own nuclear-related technologies, instead of buying them abroad, was a constant of Argentina's nuclear programme conducted by the civilian National Atomic Energy Commission (CNEA). Nuclear facilities with Argentine technology have been built in Peru, Algeria, Australia and Egypt. In 1983, the country admitted having the capability of producing weapon-grade uranium, a major step needed to assemble nuclear weapons; since then, however, Argentina has pledged to use nuclear power only for peaceful purposes. As a member of the Board of Governors of the International Atomic Energy Agency, Argentina has been a strong voice in support of nuclear non-proliferation efforts and is highly committed to global nuclear security.
  
  Despite its modest budget and numerous setbacks, academics and the sciences in Argentina have enjoyed international respect since the turn of the 1900s, when Luis Agote devised the first safe and effective means of blood transfusion as well as René Favaloro, who was a pioneer in the improvement of the coronary artery bypass surgery. Argentine scientists are still on the cutting edge in fields such as nanotechnology, physics, computer sciences, molecular biology, oncology, ecology and cardiology. Juan Maldacena, an Argentine-American scientist, is a leading figure in string theory.
  
  Space research has also become increasingly active in Argentina. Argentine-built satellites include LUSAT-1 (1990), Víctor-1 (1996), PEHUENSAT-1 (2007), and those developed by CONAE, the Argentine space agency, of the SAC series. Argentina has its own satellite programme, nuclear power station designs (4th generation) and public nuclear energy company INVAP, which provides several countries with nuclear reactors. Established in 1991, the CONAE has since launched two satellites successfully and, in June 2009, secured an agreement with the European Space Agency for the installation of a 35-m diameter antenna and other mission support facilities at the Pierre Auger Observatory, the world's foremost cosmic ray observatory. The facility will contribute to numerous ESA space probes, as well as CONAE's own, domestic research projects. Chosen from 20 potential sites and one of only three such ESA installations in the world, the new antenna will create a triangulation which will allow the ESA to ensure mission coverage around the clock Argentina was ranked 73rd in the Global Innovation Index in 2023.